Usha Sharma

India has announced the revised guidelines on similar biologics to address the regulatory requirements for marketing authorisation…

The two-day conference discussed various innovations in the pharma formulations and its relevance in today's world

Fortune lauded Cipla for “driving prices down for much-needed medications

It is indicated for the treatment of patients with hypokalemia, with or without metabolic alkalosis, in digitalis intoxications…

The respiratory market is expected to rise considerably from $28.1 billion in 2015 to $46.6 billion by 2022, at a CAGR of 7.5 per…

To carve out API commodity division as increasing compliance costs cut margins

The team in Mumbai will serve the needs for cloud and mobility solutions among life sciences customers throughout India,…

The facility has approvals from US, EU, Australia, Japan, Korea, Mexico regulatory agencies

The acquisition is expected to expand Lonza’s offerings into new areas such as cognitive and diabetic health

Both will take charge of their new positions from September 1, 2016